{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:21:07Z","timestamp":1776194467953,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Primary Sj\u00f6gren disease is a chronic autoimmune disorder that impairs the peripheral and central nervous systems. No cases of metronidazole (MNZ)-induced encephalopathy (MIE) in patients with primary Sj\u00f6gren disease have been reported. Herein, we present the case of a patient with primary Sj\u00f6gren disease who developed MIE. A 74-year-old woman with a history of primary Sj\u00f6gren disease and interstitial lung disease presented with progressive gait disturbance and dysarthria after prolonged MNZ administration. In addition, the patient had right facial palsy and ataxia of the trunk and extremities. Diffusion-weighted brain magnetic resonance imaging revealed symmetric hyperintense signals in the splenium of the corpus callosum and bilateral dentate nuclei, which were suggestive of MIE. MNZ was immediately discontinued, leading to rapid improvement in neurological impairments. Additionally, improvement in intracranial lesions was observed on brain magnetic resonance imaging. To our knowledge, this is the first reported case of MIE in a patient with primary Sj\u00f6gren disease. Our case suggests the importance of a comprehensive investigation of the causes of neurological manifestations in patients with primary Sj\u00f6gren disease, while considering other autoimmune diseases and drug induction.<\/jats:p>","DOI":"10.1093\/mrcr\/rxag019","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:49:43Z","timestamp":1772628583000},"source":"Crossref","is-referenced-by-count":1,"title":["Metronidazole-induced encephalopathy in a patient with primary Sj\u00f6gren disease"],"prefix":"10.1093","volume":"10","author":[{"given":"So","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-3136","authenticated-orcid":false,"given":"Shuhei","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aren","family":"Fueki","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Otaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomu","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8110-8261","authenticated-orcid":false,"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Kanai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Shimojima","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine , Fukushima ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"2026041414314932100_ref1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41584-025-01268-z","article-title":"2023 International Rome consensus for the nomenclature of Sj\u00f6gren disease","volume":"21","author":"Ramos-Casals","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"2026041414314932100_ref2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"2026041414314932100_ref3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12868-018-0427-y","article-title":"Clinical features and risk factors of neurological involvement in Sj\u00f6gren's syndrome","volume":"19","author":"Ye","year":"2018","journal-title":"BMC Neurosci"},{"key":"2026041414314932100_ref4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1055\/s-0043-1777105","article-title":"Sjogren's syndrome: a neurological perspective","volume":"81","author":"Barsottini","year":"2023","journal-title":"Arq Neuropsiquiatr"},{"key":"2026041414314932100_ref5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1212\/WNL.45.3.588","article-title":"Reversible magnetic resonance imaging findings in metronidazole-induced encephalopathy","volume":"45","author":"Ahmed","year":"1995","journal-title":"Neurology"},{"key":"2026041414314932100_ref6","first-page":"103","article-title":"Primary Sj\u00f6gren's syndrome: central and peripheral nervous system involvements","volume":"38","author":"Mekinian","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2026041414314932100_ref7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/RHU.0000000000001128","article-title":"Neurological involvement in patients with primary Sj\u00f6gren's syndrome","volume":"27","author":"Fan","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"2026041414314932100_ref8","first-page":"13:14.","article-title":"Central nervous system involvement in primary Sj\u00f6gren's syndrome: narrative review of MRI findings","author":"M\u00f3dis","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026041414314932100_ref9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10067-022-06448-w","article-title":"Clinical features and high-risk indicators of central nervous system involvement in primary Sj\u00f6gren's syndrome","volume":"42","author":"Fan","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2026041414314932100_ref10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3182334b35","article-title":"Metronidazole-induced central nervous system toxicity: a systematic review","volume":"34","author":"Kuriyama","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"2026041414314932100_ref11","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.ijid.2008.03.006","article-title":"Cerebellar ataxia following prolonged use of metronidazole: case report and literature review","volume":"12","author":"Patel","year":"2008","journal-title":"Int J Infect Dis"},{"key":"2026041414314932100_ref12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinthera.2024.02.003","article-title":"Association between first-time neurologic events and metronidazole treatment: a case-time control study","volume":"46","author":"Andersen","year":"2024","journal-title":"Clin Ther"},{"key":"2026041414314932100_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-018-9147-6","article-title":"Metronidazole-induced encephalopathy: a systematic review","volume":"267","author":"S\u00f8rensen","year":"2020","journal-title":"J Neurol"},{"key":"2026041414314932100_ref14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clinthera.2010.01.018","article-title":"Irreversible encephalopathy after treatment with high-dose intravenous metronidazole","volume":"32","author":"Groothoff","year":"2010","journal-title":"Clin Ther"},{"key":"2026041414314932100_ref15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12028-014-0102-9","article-title":"Metronidazole-induced encephalopathy: not always a reversible situation","volume":"22","author":"Hobbs","year":"2015","journal-title":"Neurocrit Care"},{"key":"2026041414314932100_ref16","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00004728-200211000-00016","article-title":"Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy","volume":"26","author":"Cecil","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"2026041414314932100_ref17","first-page":"Oe01","article-title":"Clinical and neuroradiological spectrum of metronidazole induced encephalopathy: our experience and the review of literature","volume":"10","author":"Roy","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"2026041414314932100_ref18","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2026041414314932100_ref19","doi-asserted-by":"crossref","first-page":"103503","DOI":"10.1016\/j.nicl.2023.103503","article-title":"Changes in levels of the antioxidant glutathione in brain and blood across the age span of healthy adults: a systematic review","volume":"40","author":"Detcheverry","year":"2023","journal-title":"Neuroimage Clin"},{"key":"2026041414314932100_ref20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuron.2024.10.019","article-title":"White matter aging and its impact on brain function","volume":"113","author":"Groh","year":"2025","journal-title":"Neuron"},{"key":"2026041414314932100_ref21","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1212\/WNL.31.11.1391","article-title":"Sj\u00f6gren syndrome: central nervous system manifestations","volume":"31","author":"Alexander","year":"1981","journal-title":"Neurology"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxag019\/67248975\/rxag019.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag019\/67248975\/rxag019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/10\/1\/rxag019\/67248975\/rxag019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T18:31:57Z","timestamp":1776191517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxag019\/8507945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxag019","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rxag019"}}